Literature DB >> 19811432

Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells.

Maria Carmela Latella1, Monica de Gaetano, Augusto Di Castelnuovo, Emanuela Napoleone, Roberto Lorenzet, Marinella Gattone, Pantaleo Giannuzzi, John Rogus, Kenneth Huttner, Maria Benedetta Donati, Licia Iacoviello.   

Abstract

The objective was to investigate whether genotypes, haplotypes and haplotype-pairs of interleukin (IL) gene cluster are associated with risk of Myocardial Infarction (MI) at young age and with the release of IL-1B and expression of tissue factor pro-coagulant activity (TFPCA), after stimulation in vitro with lipopolysaccharide (LPS) of human peripheral blood mononuclear cells (PBMCs). Patients with MI at young age, frequency-matched for age, sex and recruitment centre, with healthy population-based controls and PBMCs from healthy volunteers were studied. Five single nucleotide polymorphisms (SNPs), identifying two haplotype-blocks, in IL-1B gene and one SNP in IL-1A and IL-RA genes were genotyped. In multivariate analyses, haplotype A2 (122) and A4 (112) were associated with decreased risk of MI [OR = 0.62 (95% CI = 0.40-0.95), p = 0.01; OR = 0.69 (95% CI = 0.51-0.92), p = 0.03, respectively]. Haplotype-pair A2/A2 showed significant reduction in the risk of MI [OR = 0.38 (95% CI = 0.18-0.81); p = 0.01]. Haplotype A2 and A4 were associated with lower levels of IL-1B (respectively p = 0.01; p = 0.04, multivariate analysis) and haplotype-pair A2/A4 showed decreased levels of IL-1beta (p = 0.02). No association was found between block "B" IL-1B haplotypes or IL-1A and IL-RA polymorphisms and risk of MI. IL-1B haplotypes influence the inflammatory response of human mononuclear cells to LPS and affect the risk of MI at young age.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811432     DOI: 10.1080/08820130902766142

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  5 in total

1.  Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).

Authors:  Sotirios Tsimikas; Gordon W Duff; Peter B Berger; John Rogus; Kenneth Huttner; Paul Clopton; Emmanuel Brilakis; Kenneth S Kornman; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2014-02-12       Impact factor: 24.094

2.  Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study.

Authors:  Jakob Gerhard Stegger; Erik Berg Schmidt; Anne Tjønneland; Tine Iskov Kopp; Thorkild I A Sørensen; Ulla Vogel; Kim Overvad
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 3.  Biosensor and Lab-on-a-chip Biomarker-identifying Technologies for Oral and Periodontal Diseases.

Authors:  Larissa Steigmann; Shogo Maekawa; Corneliu Sima; Suncica Travan; Chin-Wei Wang; William V Giannobile
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

Review 4.  Association between IL-1β + 3954C/T polymorphism and myocardial infarction risk: A meta-analysis.

Authors:  Yizhen Fang; Huabin Xie; Zhiyuan Lin
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

5.  Polymorphism of Interleukin-1 Gene Cluster in Polish Patients with Acute Coronary Syndrome.

Authors:  Tomasz Rechciński; Bożena Szymańska; Karina Wierzbowska-Drabik; Magdalena Chmiela; Agnieszka Matusiak; Małgorzata Kurpesa; Janusz Wróblewski; Jarosław D Kasprzak
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.